JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES

Lobbying client · California · filed 2025 to 2026

Pharmaceuticals.

$280,000 Reported spend

7 Filings counted

1 Outside firm hired

8 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (203232), filed by the registrant listed below.

Who filed for this client 1

MARSHALL & POPP, LLC $280,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 8

H.R. 946
ORPHAN Cures Act

4 filings
H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

3 filings
H. Con. Res. 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…

2 filings
S. 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2 filings
H.R. 1
One Big Beautiful Bill Act

1 filing
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

1 filing
H.R. 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…

1 filing
S. Con. Res. 7
An original concurrent resolution setting forth the congressional budget for the United States Government for…

1 filing

Reported by year 2 years

2026 $120,000 3 filings
2025 $160,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Centers For Medicare and Medicaid Services (CMS) 7
Food & Drug Administration (FDA) 7
Health & Human Services, Dept of (HHS) 7
HOUSE OF REPRESENTATIVES 7
SENATE 7
Natl Economic Council (NEC) 4

Recent filings 7 total

Q3 report

MARSHALL & POPP, LLC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026

View → Q2 report

MARSHALL & POPP, LLC

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 9, 2026

View → Q1 report

MARSHALL & POPP, LLC

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 17, 2026

View → Q4 report

MARSHALL & POPP, LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 16, 2026

View → Q3 report

MARSHALL & POPP, LLC

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2 report

MARSHALL & POPP, LLC

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 21, 2025

View → Q1 report

MARSHALL & POPP, LLC

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 21, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.